Your session is about to expire
← Back to Search
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
N/A
Waitlist Available
Led By Joshua Pevnick
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
OR
10 or more prescription medications at admission
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hospitalization to the same hospital or ed visit within 30 days of discharge
Awards & highlights
Study Summary
This trial is testing a medication management intervention led by pharmacists on readmissions and emergency department visits within 30 days of discharge. The intervention focuses on evidence addressing three main areas: medication reconciliation, medication adherence, and polypharmacy.
Who is the study for?
This trial is for older adults (55+) who are at risk of medication issues after leaving the hospital. They must be taking more than 10 prescription meds or over three high-risk meds like blood thinners or diabetes drugs. It's not for those without stable housing, discharged out-of-state, in hospice care, previously enrolled, under certain specialists' care, or with COVID-19.Check my eligibility
What is being tested?
The study tests a pharmacist-led program to manage medications when patients leave the hospital. The goal is to see if this helps reduce emergency visits and readmissions within 30 days post-discharge. Patients are randomly chosen to either get this extra pharmacy help or usual care.See study design
What are the potential side effects?
Since this trial involves a service (medication management) rather than a drug, traditional side effects aren't expected. However, there may be unintended consequences related to changes in medication use as advised by pharmacists.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
This criterion does not apply to me.
Select...
I am taking 10 or more prescription medications.
Select...
I am currently admitted to a hospital ward.
Select...
I am 55 years old or older.
Select...
I am taking 3 or more high-risk medications like blood thinners or diabetes drugs.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ hospitalization to the same hospital or ed visit within 7 days of discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hospitalization to the same hospital or ed visit within 7 days of discharge
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate (%) of 30-day post-discharge hospitalization and ED visits (including hospitals at least statewide)
Secondary outcome measures
Perinatal death
Rate (%) of 30 day post-discharge hospitalizations and ED visits (same hospital) among patients who were enrolled and received the intervention, compared to patients who were eligible yet not enrolled during the study period.
Heart rate
+15 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Pharmacist ArmExperimental Treatment1 Intervention
Pharmacist-Led Medication Reconciliation, Regimen Review, and Adherence and Literacy Assessment and Counseling
Group II: Usual CareActive Control1 Intervention
Patients in this study will receive usual care. Clinically-indicated services, including pharmacist services, may be provided to control group patients.
Find a Location
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
499 Previous Clinical Trials
158,379 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
27,998,636 Total Patients Enrolled
Joshua PevnickPrincipal InvestigatorAssociate Professor of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- This criterion does not apply to me.I am taking 10 or more prescription medications.I will get medication management from a pharmacist after leaving the hospital.I am currently admitted to a hospital ward.My post-hospital care will not support the study's medication plan.I am 55 years old or older.I am taking 3 or more high-risk medications like blood thinners or diabetes drugs.I am admitted with a suspected or confirmed COVID-19 diagnosis.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Pharmacist Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there opportunities for people to enroll in this medical experiment?
"The clinicaltrials.gov page for this trial indicates that it is no longer recruiting participants, with the initial post being dated December 23rd 2019 and the last update taking place on September 7th 2022. Fortunately, there are 24 other studies accepting new patients at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger